Immune Checkpoint Inhibitor and MR-guided SBRT for Limited Progressive Metastatic Carcinoma.
Clinical trial NCT04376502 · TERMINATED
Trial details
- NCT number
- NCT04376502
- Sponsor
- Baptist Health South Florida
- Status
- TERMINATED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-08
- Primary completion
- 2023-06-16
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.